Bahrain's National Health Regulatory Authority (NHRA) on Sunday announced it has officially approved the registration of the coronavirus vaccine developed by China National Pharmaceutical Group (Sinopharm), Bahrain News Agency reported.

According to the report, the NHRA's decision to approve and use the vaccine is based on the data of clinical trials conducted in several countries, which was thoroughly reviewed and evaluated by the authority.